JVMCX | NMAVX | JVMCX / NMAVX | |
Total Expense Ratio | 1.87 | 1.19 | 157% |
Annual Report Gross Expense Ratio | 1.88 | 1.24 | 152% |
Fund Existence | 14 years | 12 years | - |
Gain YTD | 8.261 | 1.824 | 453% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 23.1B | 514M | 4,494% |
Annual Yield % from dividends | 0.00 | 2.39 | - |
Returns for 1 year | -2.28 | -2.75 | 83% |
Returns for 3 years | 12.83 | -0.70 | -1,828% |
Returns for 5 years | 48.48 | 3.41 | 1,423% |
Returns for 10 years | 34.55 | 31.22 | 111% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SDCI | 22.34 | 0.20 | +0.88% |
USCF SummerHaven Dyn CmdtyStgy NoK-1 ETF | |||
IYW | 181.29 | 1.31 | +0.73% |
iShares US Technology ETF | |||
RMNY | 23.72 | 0.09 | +0.40% |
Rockefeller New York Municipal Bond ETF | |||
HFRO | 5.20 | -0.03 | -0.57% |
Highland Opportunities and Income Fund | |||
GNOM | 8.95 | -0.06 | -0.72% |
Global X Genomics & Biotechnology ETF |